FENNEC PHARMACEUTICALS INC revenue for the last year amounted to 28.17 M CAD, the most of which — 28.68 M CAD — came from its highest performing source at the moment, Sodium Thiosulfate, the year earlier bringing 2.00 M CAD. The greatest contribution to the revenue figure was made by United States — last year it brought FENNEC PHARMACEUTICALS INC 28.68 M CAD, and the year before that — 2.00 M CAD.